top of page

BLUEBERRIES MEDICAL CORP ANNUAL GENERAL MEETING 2024

BBM Financial Statement Request - Return Card 2025

Information Circular Sept. 16 - 2025

Notice of AGM 2025

​OSOQ SEDAR Proxy English

INFORMACIÓN
GENERAL

Blueberries Medical Corp. es una compañía latinoamericana con todas las licencias otorgadas por los Ministerios de Justicia y Salud de Colombia, necesarias para producir cannabis de alta calidad, con bajos y altos contenidos de THC. Produce, comercializa, y exportar ingredientes derivados de Cannabis. Sus operaciones se centran principalmente en la Sabana de Bogotá, en el centro de Colombia.

​

Blueberries Medical Corp cotiza en los siguientes mercados: (CSE: BBM) (OTC: BBRRF) (FRA: 1OA)

PRESENTACIÓN INVERSIONISTAS

2025

Q4 2024

Audited Consolidated Financial Statements For The Year Ended December 31, 2024

Management’s Discussion And Analysis Of Financial Condition And Results Of Operations For The Three And Twelve Months Ended December 31, 2024

Q3 2024

Condensed Interim Consolidated Financial Statements For The Three And Nine Months Ended September 30, 2024

Management’s Discussion And Analysis Of Financial Condition And Results Of Operations For The Three And Nine Months Ended September 30, 2024

Q2 2025

Condensed Interim Consolidated Financial Statements For The Six Months Ended June 30, 2025

Management’s Discussion And Analysis Of Financial Condition And Results Of Operations For The Six Months Ended June 30, 2025

Q1 2025

Condensed Interim Consolidated Financial Statements For The Three Months Ended March 31, 2025

​

Management’s Discussion And Analysis Of Financial Condition And Results Of Operations For The Three Months Ended March 31, 2025

RELACIÓN CON INVERSIONISTAS

Thomas Pablo Rodriguez Prats

CFO 

     trodriguez@blueberriesmed.com

     +57 3116174246

STOCK INFORMATION
bottom of page